LYSOGENE - FR 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 11.938.569 0 1
2020 0 11.773.000 450.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA2
NOVO NORDISK2
PFIZER LIMITED2
SANOFIAVENTIS2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
ASPHALION SL1
ASTELLAS PHARMA EUROPE BV1
BAYER1
BULGARIAN ASSOCIATION FOR PERSONALIZED MEDICINE1
BULGARIAN ASSOCIATION FOR PROMOTION OF EDUCATION AND SCIENCE1
CENTRE DE REGULACIO GENOMICA1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHARLES UNIVERSITY PRAGUE1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSORZIO FUTURO IN RICERCA1
COPENHAGEN BUSINESS SCHOOL1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
F HOFFMANNLA ROCHE1
FINDZEBRA APS1
GENETHON1
GENOSAFE SAS1
GNX DATA SYSTEMS1
ILLUMINA CAMBRIDGE LIMITED1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
JANSSEN PHARMACEUTICA NV1
LONZA1
LUDWIG BOLTZMANN GESELLSCHAFT1
LUND UNIVERSITY1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MIMETAS BV1
OSPEDALE PEDIATRICO BAMBINO GESU1
PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT1
PROQR THERAPEUTICS NV1
PTC THERAPEUTICS INTERNATIONAL LIMITED1
RESEARCH INSTITUTE AG & CO KG1
SBA RESEARCH GEMEINNUTZIGE1
SITEMINSEL1
SPARK THERAPEUTICS INC1
SYDDANSK UNIVERSITET1
SYNVACCINE1
TAKIS1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE ROSALIND FRANKLIN INSTITUTE1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF SHEFFIELD1
UNIVERSITA DEGLI STUDI DI FERRARA1
UNIVERSITA DEGLI STUDI DI SIENA1
UNIVERSITAET BERN1
UNIVERSITAETSKLINIKUM FREIBURG1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS1
UNIVERSITATSKLINIKUM BONN1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF EASTERN FINLAND1
UPPSALA UNIVERSITET1
VISCOFAN1

Constancy:

Total number of partners: 69
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 69
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-10-01Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies SCREEN4CAREparticipant11.938.56937
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034